Arrhythmias and conduction disturbance
Relation of QRS Width in Healthy Persons to Risk of Future Permanent Pacemaker Implantation

https://doi.org/10.1016/j.amjcard.2010.04.021Get rights and content

In the setting of acute myocardial infarction, prolongation of the QRS interval on electrocardiography identifies patients at risk for needing permanent pacemaker implantation. However, the implications of prolonged QRS intervals in healthy subjects are unclear, especially given that the QRS prolongation encountered in this setting is typically mild. The aim of this study was to assess the relation between QRS duration and incident pacemaker implantation in a community-based cohort of 8,311 subjects (mean age 54 years, 55% women) who attended 17,731 routine examinations with resting 12-lead electrocardiography. QRS duration was analyzed as a continuous and a categorical variable (<100, 100 to <120, and ≥120 ms). During up to 35 years of follow-up, 157 participants (56 women) developed need for permanent pacemakers. In multivariable Cox regression models adjusting for cardiovascular risk factors and previous myocardial infarction or heart failure, mild QRS prolongation was associated with a threefold risk for pacemaker implantation (adjusted hazard ratio 2.90, 95% confidence interval 1.81 to 4.66, p <0.0001), and bundle branch block was associated with a fourfold risk for pacemaker implantation (hazard ratio 4.43, 95% confidence interval 2.94 to 6.68, p <0.0001). Each standard deviation increment in QRS duration (11 ms) was associated with an adjusted hazard ratio of 1.14 (95% confidence interval 1.11 to 1.18, p <0.0001) for pacemaker placement. This association remained significant after excluding subjects with QRS durations ≥120 ms. In conclusion, subjects with prolonged QRS durations, even without bundle branch block, are at increased risk for future pacemaker implantation. Such individuals may warrant monitoring for progressive conduction disease.

Section snippets

Methods

The design and selection criteria of the Original and Offspring cohorts of the Framingham Heart Study (FHS) have been described previously.9, 10 In this study, we used pooled epochs from repeated examinations. Original cohort participants were eligible if they attended examination 11 (1968 to 1971, n = 2,955), examination 17 (1981 to 1984, n = 2,179), or examination 23 (1993 to 1995, n = 1,026). Offspring cohort participants were eligible if they attended examination 1 (1971 to 1975, n =

Results

The study cohort (17,731 examinations) was aged 20 to 98 years, and 55% were women, as listed in Table 1. Across all examinations, 40% of subjects had hypertension, and only 4% had histories of myocardial infarction or heart failure. The mean QRS duration was 79 ± 14 ms; 93% had QRS durations <100 ms, 4% had mild QRS prolongation (100 to <120 ms), and 3% had QRS durations ≥120 ms.

During follow-up, 157 participants (56 women) had permanent pacemakers implanted. Pacemakers were implanted

Discussion

Our results suggest that individuals in the community with even mildly prolonged QRS intervals are at substantially increased risk for developing cardiac rhythm disturbances severe enough to require pacemaker implantation. Mild QRS prolongation and bundle branch block were associated with three- and fourfold risks for incident pacemaker implantation, respectively. Furthermore, we observed a graded increase in the risk for pacemaker events across increasing QRS values, even after excluding those

Cited by (22)

  • Progressive Conduction System Disease

    2018, Cardiac Electrophysiology: From Cell to Bedside: Seventh Edition
  • Electrocardiographic abnormalities and arrhythmic risk markers in adult patients with beta thalassemia major

    2016, International Journal of Cardiology
    Citation Excerpt :

    QRS duration has been examined only in one small case–control study which failed to demonstrate any difference [10]. It has been demonstrated that increased QRS duration, even within normal limits, predicts mortality in the general population while it has been associated with increased risk for pacemaker implantation due to progressive conduction disease [26,27]. QRS fragmentation represents an abnormality in ventricular depolarization that has been associated with increased risk of arrhythmic events and mortality in a variety of cardiac disorders [28].

  • Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve

    2014, JACC: Cardiovascular Interventions
    Citation Excerpt :

    These differences between studies may partially explain the controversial results regarding the clinical impact of new LBBB after TAVI, but this will need to be further evaluated in future studies. A high risk of AVB has been observed in patients and individuals without overt cardiac disease in the presence of LBBB (27,28). Previous studies including a relatively small number of patients showed a higher rate of PPI at follow-up among those patients in whom a new LBBB developed after either SAVR or TAVI (2,11,29).

  • Progressive Conduction System Disease

    2014, Cardiac Electrophysiology: From Cell to Bedside: Sixth Edition
  • The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development

    2013, American Heart Journal
    Citation Excerpt :

    In the absence of underlying heart disease, the presence of rate-dependent bundle-branch block does not necessarily indicate an impaired prognosis.29 However, a recent prospective study has suggested that QRS duration independently predicts risk of sudden cardiac death, with a 2.5-fold elevated risk in subjects with a QRS >110 ms compared with those with a QRS <96 ms.30 Additionally, QRS prolongation in CV patients may portend a worsened outcome.31,32 Pathologic causes of bundle-branch block include ischemic heart disease, hypertrophy, endocarditis, myocarditis, cardiomyopathy, congenital defects, massive pulmonary embolus, age-dependent degenerative changes, or drug effect (eg, sodium channel blockers).

View all citing articles on Scopus

This work was supported by the Framingham Heart Study of the National Heart, Lung, and Blood Institute, Bethesda, Maryland (Contract Number N01-HC-25195).

View full text